CLINICAL_TRIALS
trial_result
· 2020-01-13
Clinical Trial Update: Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa [Phase 2]
Summary
Phase 2 trial update on SD-101 for Epidermolysis Bullosa has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Scioderm, Inc. | Conditions: Epidermolysis Bullosa | Phase 2 | Status: COMPLETED | Results posted: 2020-01-13